DNMT1 and acute lymphoblastic leukemia: It appears that further studies regarding the quantitative assessment of DNMT1 promoter methylation among the different subtypes of ALL, and the comparison of their methylation pattern with expression profiles of genes involved in disease recurrence would also be helpful for the accurate prediction of disease progression and response to treatment.